IAIM
NUVB icon

International Assets Investment Management’s Nuvation Bio NUVB Stock Holding History

International Assets Investment Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.21K Sell
1,700
-200
-11% -$978 ﹤0.01% 1825
2026
Q1 		$8.57K Buy
1,900
+100
+6% +$557 ﹤0.01% 1719
2025
Q4 		$16.1K Buy
+1,800
New +$11.2K ﹤0.01% 1537

Other funds holding NUVB

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

International Assets Investment Management's NUVB Position: Q2 2026 in Review

International Assets Investment Management reduced its Nuvation Bio (NUVB) stake by 11% in Q2 2026, selling an estimated $978 and leaving 1,700 shares worth $9.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

International Assets Investment Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.1K in Q4 2025. 66 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • International Assets Investment Management held 1,700 shares of Nuvation Bio worth $9.21K as of Q2 2026.
  • International Assets Investment Management sold 200 Nuvation Bio shares in Q2 2026, an estimated $978.
  • Nuvation Bio made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1825 holding.
  • International Assets Investment Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • International Assets Investment Management's Nuvation Bio position peaked at $16.1K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.